Immune phenotypes in lung cancer patients with COPD: potential implications for immunotherapy

Lung cancer remains one of the most commonly diagnosed neoplasms, being responsible for the majority of cancer-related deaths worldwide (1,2). Chronic obstructive pulmonary disease (COPD) is also a major cause of morbidity and mortality globally. COPD underlies lung cancer in the majority of the patients.